Nolan A Wages

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Topics

Finite Element Analysis

Top Venues

Clinical trials (London, England)

Statistics in medicine

Cancer immunology, immunotherapy : CII

Journal of clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Nolan A Wages, Patrick M Dillon, Craig A Portell, Craig L Slingluff, Gina R Petroni
Applications of the partial-order continual reassessment method in the early development of treatment combinations. Clinical trials (London, England) 21 (3) (2024)
Nolan A Wages, Patrick M Dillon, Craig A Portell, Craig L Slingluff, Gina R Petroni
Applications of the partial-order continual reassessment method in the early development of treatment combinations. Clinical trials (London, England) (2024)
Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, Susan Halabi, Ying Kuen Cheung
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus. Clinical trials (London, England) 21 (3) (2024)
Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, Susan Halabi, Ying Kuen Cheung
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus. Clinical trials (London, England) 21 (3) (2024)
Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, Susan Halabi, Ying Kuen Cheung
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus. Clinical trials (London, England) 21 (3) (2024)
Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, Susan Halabi, Ying Kuen Cheung
Current issues in dose-finding designs: A response to the US Food and Drug Adminstrations's oncology center of excellence project optimus. Clinical trials (London, England) (2024)
Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, Susan Halabi, Ying Kuen Cheung
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus. Clinical trials (London, England) 21 (3) (2024)
Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, Susan Halabi, Ying Kuen Cheung
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus. Clinical trials (London, England) 21 (3) (2024)
Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, Susan Halabi, Ying Kuen Cheung
Current issues in dose-finding designs: A response to the US Food and Drug Adminstrations's Oncology Center of Excellence Project Optimus. Clinical trials (London, England) (2024)
Nolan A Wages, Ramy R Saleh, Thomas M Braun
Concurrent dose-finding of a novel cancer drug with and without a second agent. Journal of clinical and translational science 7 (1) (2023)
Miyabi Saito, Nolan A Wages, David Schiff
Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma. Journal of neuro-oncology 154 (1) (2021)
Nolan A Wages, Daniel R Reed, Michael K Keng, Mark R Conaway, Gina R Petroni
Adapting isotonic dose-finding to a dynamic set of drug combinations with application to a phase I leukemia trial. Clinical trials (London, England) 18 (3) (2021)
Nolan A Wages, Craig L Slingluff, Timothy N Bullock, Gina R Petroni
Tailoring early-phase clinical trial design to address multiple research objectives. Cancer immunology, immunotherapy : CII 69 (1) (2019)
Nolan A Wages, Alexia Iasonos, John O'Quigley, Mark R Conaway
Coherence principles in interval-based dose finding. Pharmaceutical statistics 19 (2) (2019)
Nolan A Wages, Camilo E Fadul
Adaptive dose-finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy. Clinical trials (London, England) 17 (2) (2019)
Nolan A Wages, Evan Bagley
Evaluation of irrational dose assignment definitions using the continual reassessment method. Clinical trials (London, England) 16 (6) (2019)
Bethany Jablonski Horton, Nolan A Wages, Mark R Conaway
Performance of toxicity probability interval based designs in contrast to the continual reassessment method. Statistics in medicine 36 (2) (2016)
Mark R Conaway, Nolan A Wages
Designs for phase I trials in ordered groups. Statistics in medicine 36 (2) (2016)
Alexia Iasonos, Nolan A Wages, Mark R Conaway, Ken Cheung, Ying Yuan, John O'Quigley
Dimension of model parameter space and operating characteristics in adaptive dose-finding studies. Statistics in medicine 35 (21) (2016)
Gina R Petroni, Nolan A Wages, Gautier Paux, Frédéric Dubois
Implementation of adaptive methods in early-phase clinical trials. Statistics in medicine 36 (2) (2016)
Nolan A Wages
Identifying a maximum tolerated contour in two-dimensional dose finding. Statistics in medicine 36 (2) (2016)